MYX mayne pharma group limited

Ann: Appendix 4E and Statutory Accounts, page-7

  1. 382 Posts.
    lightbulb Created with Sketch. 231

    And this is my concern.
    The company has zero success and credibility in executing it's stated plans.

    4 consecutive years of declining Gross Profit
    5 consecutive years of showing a Net Loss from operations
    4 consecutive years of declining cash receipts from customers
    5 consecutive years of declining net operating cashflow

    It all now hangs on Nextstellis and Scott Richards admits we are "behind where we expected to be with NEXTSTELLIS" but don't worry because "we saw solid growth in the key performance metrics across the second half of FY22".
    In the past 5 years it's always been presented that MYX is about to turn the corner. This year appears to be no different.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.03
Change
-0.170(3.27%)
Mkt cap ! $408.6M
Open High Low Value Volume
$5.20 $5.21 $5.03 $2.804M 555.6K

Buyers (Bids)

No. Vol. Price($)
2 14654 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.14 3111 2
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.